Exelon
Exelon is formulated to target cognitive decline and is intended to alleviate symptoms of dementia associated with Alzheimer's and Parkinson's.
- Category
- Neurology
- Active ingredient
- Rivastigmine
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Capsule, hard
- Strengths
- 1.5 · 3mg
Exelon details
- Therapeutic class
- Acetylcholinesterase Inhibitor
- Pharmacological class
- Acetylcholinesterase Inhibitor
- Contraindications
- hypersensitivity to rivastigmine; severe hepatic impairment
- Minor side effects
- nausea; vomiting; dizziness; diarrhoea
- Moderate side effects
- loss of appetite; weight loss; insomnia; abdominal pain
- Dosage forms
- Capsule, hard
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Novartis
- Onset Time
- 2–4 weeks
- Duration
- 8–12 hours
- Storage instructions
- Store at room temperature below 30°C.
- Drug interactions
- Metoclopramide; Beta-blockers; Anticholinergic agents
- Age restrictions
- For adult patients with confirmed diagnosis.
- Pregnancy and breastfeeding
- Pregnancy: Consult a specialist; data is limited. Breastfeeding: Avoid use.
Precautions and warnings
monitor weight changes; use with caution in patients with history of ulcers; risk of bradycardia; caution in asthma patients
Serious side effects
gastrointestinal ulcer, requires immediate medical attention; bradycardia, requires immediate medical attention; seizures, requires immediate medical attention
Patient summary
Exelon is formulated to target cognitive decline and is intended to alleviate symptoms of dementia associated with Alzheimer's and Parkinson's.
Mechanism of action
Exelon acts as a cholinesterase inhibitor that slows the degradation of acetylcholine, a neurotransmitter essential for memory and cognitive processes, by inhibiting acetylcholinesterase and butyrylcholinesterase enzymes.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Exelon
Exelon is a branded formulation of rivastigmine, a medication used to manage cognitive symptoms associated with dementia of Alzheimer’s type and Parkinson’s disease dementia. Produced by Novartis, this treatment is available in tablet form in strengths of 1.5mg and 3mg.
Buying Exelon online
Exelon is registered across 14 markets including Indonesia, Taiwan and South Korea, with availability also in Japan, the UAE and Singapore. As one of the most consistently demanded medications for cognitive health across the region, patients living far from a well-stocked pharmacy often prefer the convenience of ordering this treatment online. Reliable access to Novartis products helps support ongoing care for those throughout Asia.